Lakefront Biotherapeutics American Depositary Shares
LKFT
38 hedge funds and large institutions have $368M invested in Lakefront Biotherapeutics American Depositary Shares in 2015 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 17 closing their positions.
83% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 6
7% less funds holding
Funds holding: 41 → 38 (-3)
12% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 17
19% less capital invested
Capital invested by funds: $453M → $368M (-$84.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$19.4M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$17.4M |
| 3 |
Goldman Sachs
New York
|
+$9.44M |
| 4 |
Morgan Stanley
New York
|
+$3.98M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$3.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$11.6M |
| 2 |
RIM
RS Investment Management
San Francisco,
California
|
-$10.7M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$10.4M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$7.72M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$2.73M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| – | -$117K | -2,300 | Closed |
|
52
Wells Fargo
San Francisco,
California
| – | -$49K | -950 | Closed |
|
53
Invesco
Atlanta,
Georgia
| – | -$43K | -839 | Closed |
|
|
PCM
54
Prelude Capital Management
New York
| – | -$15K | -300 | Closed |
|
|
LTFS
55
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$3K | -50 | Closed |
|
LKFT Hedge Fund Activity: Q3 2015 in Review
38 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q3 2015, worth a combined $368M — down 19% from $453M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of LKFT and 15 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 11 added.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $19.4M. The largest seller was Deerfield Management, cutting an estimated $11.6M.
- 38 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q3 2015, down from 41 in Q2 2015.
- Funds reported $368M of Lakefront Biotherapeutics American Depositary Shares stock for Q3 2015, down 19% quarter-over-quarter.
- 15 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q3 2015 and 17 closed out, a net change of -2 holders.
- The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q3 2015 was Wellington Management Group, an estimated $19.4M added.
- The largest Lakefront Biotherapeutics American Depositary Shares seller in Q3 2015 was Deerfield Management, an estimated $11.6M sold.
Based on aggregated 13F filings for Q3 2015.